BridgeBio Pharma, Inc. (BBIO) Profit Breakdown
- 2026-06-30: Products $211.91M.
- 2025-06-30: Products $68.65M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Profit by product
Gross margin: each quarter (3 month)
| Quarter end | Products |
|---|
| 2026-06-30 | $211.91M
derived |
|---|
| 2025-06-30 | $68.65M
derived |
|---|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$155.89M |
|---|
| 2025-06-30 | -$181.66M |
|---|
Nonoperating Income (Expense): each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$48.81M |
|---|
| 2025-06-30 | -$47.38M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$107.08M |
|---|
| 2025-06-30 | -$134.28M |
|---|